Member Info for Soulected

I’ve bought a few more today, but it would only let me buy in 500 chunks, I should have bought them yesterday at £1.29 when I had the chance!

Thanks, yes that is what I make it, but when did it suddenly change from 1:1?

Please can anyone point me in the direction of the Accustem news release where it explains the share split? I understand that TILS split 2 to 1, but then my Accustem seem to be 10 to 1, I have only ever read that it was supposed to be a 1:1, but I only have a 10th of what I was expecting? Thanks

Just playing around on IG and if you want 3500 it is quoting 340p!

Sorry, top up was probably the wrong phrase, I just had some cash in the SIPP from a previous pension transfer and decided to use it on Faron, instead of buying a fund that I told myself I would, let’s hope I don’t live to regret it as I am by no means wealthy!

I’ve just taken another chunk for my SIPP, has to be my last top up (said that before!). Interestingly it is not showing on the trades… it was 6500, got them for 2.7865, so still stock available at this level.

That would explain recent drop!

Agreed, no RNS which I am pleased about for once!

Doesn’t sound too promising for us either...

Remdesivir has 'little effect' on COVID-19 death risks, WHO study says
https://mol.im/a/8845241

Am I right in saying that there is nothing in this we didn’t already know?

‘The presentation includes previously announced data, highlighting:‘

This was the bit I liked...

“IFN beta-1a now remains as a monotherapy.“

Think they still have another 6 months to report back due to temp extension to Aim rules. Still poor that it wasn’t mentioned in the last RNS though...

Pursuant to AIM Rule 41, where an AIM company has been suspended for more than six months, the company’s securities will be cancelled. The LSE recognises that, given the logistical challenges during this period, further time might be required to resolve the reason for suspension and indicates that it will be using discretion to extend the period to 12 months for any AIM company that has been suspended between 30 September 2019 and 1 July 2020. Nominated advisers should contact AIM Regulation if any AIM company needs this additional time to resolve the suspension of its securities and request restoration to trading.

With news so close, I still struggle to understand the total lack of any significant volume (buys or sells) of any kind in this share. Why are we so under the radar?

I took another 500 at 347.999 and showing as the only buy of the day...shows how inaccurate the reporting of trades are...

Just sold my 15,000 at 16p, so someone obviously wants some shares. I may end up regretting the sale, but as I had originally tried to tender at 15.5p I can’t complain.

Buy of 50,000 just gone through at 21.75p - seems very odd!

I use DeGiro and they managed to mess up my first request to tender my shares, now have a second chance - but curious who would spend over £10K on the share...?

All seems very positive, but why then the sluggish start on market? Still under the radar, companies seem only need to mention Covid19 in RNS and they add 50% to share price...

Should we be concerned that SNG are getting all the attention 14 million shares traded vs just 70K for Faron. Both on same Remap trial but we certainly seem to be more under the radar?

The price is not going to move much as there is no volume, if you compare this to SNG they have huge volume (I know they have 3x the shares in issue, but even so). SNG seem to be getting more press with their interferon beta-1a treatment. Does anyone know how this compares to Faron? I am invested in Faron, but still tempted by SNG as well.

Or could they be planning on giving it a new name with partner entry to disassociate from previous phase 3 results?